From: Association of sudden sensorineural hearing loss with dementia: a nationwide cohort study
Variables | Comparison cohort (N = 11,175) | SSHL cohort (N = 3725) | P value |
---|---|---|---|
N (%) | N (%) | ||
Age | 0.823 | ||
 < 40 | 2731 (24.4) | 918 (24.6) | |
 40–59 | 4484 (40.1) | 1508 (40.5) | |
 ≧60 | 3960 (35.4) | 1299 (34.9) | |
Mean (±SD) | |||
Age (years) | 52.1 (±16.4) | 52.0 (±16.4) | 0.726 |
Sex | 0.977 | ||
 Female | 5199 (46.5) | 1734 (46.6) | |
 Male | 5976 (53.5) | 1991 (53.4) | |
Insurance range | 0.640 | ||
 < NT 15,840 | 3928 (35.1) | 1339 (35.9) | |
 NT 15,841-25,000 | 4193 (37.5) | 1371 (36.8) | |
 > NT 25,001 | 3054 (27.3) | 1015 (27.2) | |
Comorbidities | |||
 Diabetes | 1613 (14.4) | 569 (15.3) | 0.209 |
 Hyperlipidemia | 2358 (21.1) | 801 (21.5) | 0.603 |
 hypertension | 3700 (33.1) | 1230 (33.0) | 0.920 |
 Depression | 1001 (9.0) | 323 (8.7) | 0.595 |
 Ischemic heart disease | 197 (1.8) | 74 (2.0) | 0.376 |
 Cerebral vascular disease | 360 (3.2) | 133 (3.6) | 0.302 |
Charlson’s index score | 0.723 | ||
 ≦1 | 8395 (75.1) | 2793 (75.0) | |
 2 | 1276 (11.4) | 414 (11.1) | |
 ≧3 | 1504 (13.5) | 518 (13.9) | |
Medications | |||
 Anticoagulant agents | 64 (0.6) | 24 (0.6) | 0.621 |
 Antiplatete agents | 366 (3.3) | 137 (3.7) | 0.239 |
 Antidiabetic agents | 1088 (9.7) | 386 (10.4) | 0.267 |
 Antihypertension agents | 2730 (24.4) | 935 (25.1) | 0.410 |
 Statin | 523 (4.7) | 190 (5.1) | 0.298 |